Kitex Garments reported strong year-on-year growth for Q2 FY2027, with standalone net profit rising to Rs 25.03 crore from Rs 10.87 crore. However, statutory auditor MSKA & Associates issued a qualified opinion regarding the recoverability of a Rs 27.76 crore investment in associate firm Kitex USA LLC, citing concerns over the subsidiary's eroded net worth and lack of sufficient evidence provided by management to justify its carrying value.
Kitex Garments Reports Profit Growth Amid Auditor Concerns
Standalone Revenue: Rs 179.81 Crore | Standalone Net Profit: Rs 25.03 Crore
Reader Takeaway: Strong operational performance is overshadowed by auditor warnings on asset recoverability for a US-based subsidiary.
What just happened
Kitex Garments released its financial results for the quarter ended September 30, 2026, showing significant growth in both standalone and consolidated operations. However, the report includes a qualified opinion from the statutory auditor, MSKA & Associates, concerning the company’s Rs 27.76 crore investment in its associate entity, Kitex USA LLC.
Why this matters
While the company’s core business shows robust year-on-year expansion, the auditor’s qualification flags potential financial risk. The auditor stated that Kitex USA LLC has suffered continuous losses and its net worth has eroded. Because management has not provided sufficient evidence to prove the investment's carrying value is recoverable, the auditor was unable to certify this asset, signaling a potential need for future impairment charges.
Financial Performance
Kitex Garments delivered strong standalone figures, with revenue from operations reaching Rs 179.81 crore compared to Rs 120.10 crore in the same period last year. Consolidated revenue also jumped to Rs 203.04 crore, with the group turning a net profit of Rs 13.71 crore, marking a turnaround from the Rs 6.22 crore loss recorded in the corresponding quarter of the previous year.
Risks to watch
Investors should closely track management's strategy regarding Kitex USA LLC. Any admission of impairment in subsequent quarters would directly impact the bottom line. Shareholders should look for updates in future filings regarding whether the company will provide further documentation or adjust the valuation of this associate entity.
What to track next
The market will likely react to the auditor’s note regarding the lack of evidence for the associate’s valuation. Future management commentary on the financial health of the US business will be critical for long-term sentiment.